Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
biotech
5
×
boston blog main
boston top stories
fda
5
×
life sciences
national blog main
national top stories
5
×
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
ipo
medical devices
national
biofourmis
cancer
chronic kidney disease
crispr
glaxosmithkline
investing
messenger rna
novartis
parkinson's disease
What
therapeutics
5
×
million
bio
companies
immunotherapy
ipo
life
new
raised
roundup
science
treat
week
agency
aimmune
allergy
allogene
analytics
approval
approved
awarded
biofourmis
biotechs
black
cancer
club
continue
continued
crispr
crop
data
debut
developed
devices
diamond
diamond’s
digital
diversity
drug
employs
Language
unset
Current search:
biotech
×
fda
×
" national top stories "
×
photo
×
therapeutics
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M